Bora Pharmaceuticals set to shake up rare disease treatment with Pyros Pharmaceuticals acquisition
Bora Pharmaceuticals Co., Ltd. is intensifying its presence in the rare disease treatment market by acquiring U.S.-based Pyros Pharmaceuticals, a company focused on specialized rare ... Read More
Lupin receives FDA nod for Chlorpromazine Hydrochloride Tablets
Lupin Inc., a wholly-owned subsidiary of the global pharmaceutical major Lupin Limited, announced that it has received approval from the United States Food and Drug ... Read More
Upsher-Smith Laboratories launches three generic drugs in US
Upsher-Smith Laboratories has launched three new products - Fluvoxamine Maleate Tablets, Clonidine Hydrochloride Extended-Release Tablets, and Haloperidol Tablets, USP, to expand its generic portfolio. According ... Read More